EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H20F3N7O |
| Net Charge | 0 |
| Average Mass | 455.444 |
| Monoisotopic Mass | 455.16814 |
| SMILES | CC(C)n1nc(-c2ccc(N/C(O)=N/c3cccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21 |
| InChI | InChI=1S/C22H20F3N7O/c1-12(2)32-20-17(19(26)27-11-28-20)18(31-32)13-6-8-15(9-7-13)29-21(33)30-16-5-3-4-14(10-16)22(23,24)25/h3-12H,1-2H3,(H2,26,27,28)(H2,29,30,33) |
| InChIKey | LEERPLGXOHLQPF-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | mTOR inhibitor A protein kinase inhibitor of the mammalian target of rapamycin (mTOR), a protein that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis and transcription. mTOR inhibitors are used to prevent transplant rejection and in treatment of cancer. EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| AD57 (CHEBI:233980) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| AD57 (CHEBI:233980) has role mTOR inhibitor (CHEBI:68481) |
| AD57 (CHEBI:233980) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| 1-[4-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea |
| Citations |
|---|